Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation

Blood

Volumn 100, Issue 12, 2002, Pages 4040-4048

  Maccarrone, Mauro ^a   Bari, Monica ^a   Battista, Natalia ^a   Finazzi Agrò, Alessandro ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; 5,8,11,14 ICOSATETRAYNOIC ACID; ADENOSINE DIPHOSPHATE; ALPHA CYANO 3 ETHOXY 4 HYDROXY 5 (PHENYLTHIOMETHYL)CINNAMAMIDE; ANANDAMIDE; ARACHIDONATE 15 LIPOXYGENASE; CALCIUM ION; CANNABIDIOL; CAPSAICIN; CAPSAZEPINE; CELL SURFACE RECEPTOR; CYCLIC AMP; DEXANABINOL; ESTROGEN; FATTY ACID AMIDASE; FULVESTRANT; MEMBRANE RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRITE; PHOSPHOLIPASE D; RIMONABANT; SEROTONIN; SURAMIN; TAMOXIFEN;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISSOCIATION CONSTANT; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ASSAY; ESTROGEN BINDING; ESTROGEN THERAPY; HUMAN; HUMAN CELL; MEMBRANE TRANSPORT; MOLECULAR WEIGHT; POSTMENOPAUSE; PRIORITY JOURNAL; RECEPTOR BINDING; THROMBOCYTE ACTIVATION;

EID: 0036891996     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-05-1444     Document Type: Article

References (50)

1. Bar J, Lahav J, Hod M, Ben-Rafael Z, Weinberger I, Brosens J. Regulation of platelet aggregation and adenosine triphosphate release in vitro by 17β-estradiol and medroxyprogesterone acetate in postmenopausal women. Thromb Haemost. 2000;84:695-700.
2. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340:1801-1811.
3. Sachais BS. Platelet-endothelial interactions in atherosclerosis. Curr Atheroscler Rep. 2001;3:412-416.
4. Nealen ML, Vijayan KV, Bolton E, Bray PF. Human platelets contain a glycosylated estrogen receptor beta. Circ Res. 2001;88:438-442.
5. Stefano GB, Prevot V, Beauvillain JC, et al. Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia. Circulation. 2000;101:1594-1597.
6. Stefano GB, Cadet P, Breton C, et al. Estradiol-stimulated nitric oxide release in human granulocytes is dependent on intracellular calcium transients: evidence of a cell surface estrogen receptor. Blood. 2000;95:3951-3958.
7. Maccarrone M, Bari M, Lorenzon T, Bisogno T, Di Marzo V, Finazzi-Agrò A. Anandamide uptake by human endothelial cells and its regulation by nitric oxide. J Biol Chem. 2000;275:13484-13492.
8. Di Marzo V. "Endocannabinoids" and other fatty acid derivatives with cannabimimetic properties: Biochemistry and possible physiopathological relevance. Biochim Biophys Acta. 1998;1392:153-175.
9. Hanus L, Abu-Lafi S, Fride E, et al. 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc Natl Acad Sci U S A. 2001;98:3662-3665.
10. Hansen HS, Moesgaard B, Hansen HH, Petersen G. N-Acylethanolamines and precursor phospholipids-relation to cell injury. Chem Phys Lipids. 2000;108:135-150.
11. Di Marzo V, Bisogno T, De Petrocellis L. Anandamide: Some like it hot. Trends Pharmacol Sci. 2001;22:346-349.
12. Kunos G, Jarai Z, Batkai S, et al. Endocannabinoids as cardiovascular modulators. Chem Phys Lipids. 2000;108:159-168.
13. Maccarrone M, Bari M, Menichelli A, Del Principe D, Finazzi-Agrò A. Anandamide activates human platelets through a pathway independent of the arachidonate cascade. FEBS Lett. 1999;447:277-282.
14. Maccarrone M, Bari M, Menichelli A, Giutiani E, Del Principe D, Finazzi-Agrò A. Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor. Eur J Biochem. 2001;268:819-825.
15. Batkai S, Jȧrai Z, Wagner JA, et al. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med. 2001;7:827-832.
16. Alberich Jordà M, Verbakel SE, Valk PJ, et al. Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. Blood. 2002;99:2786-2793.
17. Walker JM, Huang SM, Strangman NM, Tsou K, Sañudo-Peña MC. Pain modulation by release of the endogenous cannabinoid anandamide. Proc Natl Acad Sci U S A. 1999;96:12198-12203.
18. Berdyshev EV. Cannabinoid receptors and the regulation of immune response. Chem Phys Lipids. 2000;108:169-190.
19. Hillard CJ, Jarrahian A. The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. Chem Phys Lipids. 2000;108:123-134.
20. Ueda N, Puffenbarger RA, Yamamoto S, Deutsch DG. The fatty acid amide hydrolase (FAAH). Chem Phys Lipids. 2000;108:107-121.
21. Maccarrone M, Valensise H, Bari M, Lazzarin N, Romanini C, Finazzi-Agrò A. Progesterone upregulates anandamide hydrolase in human lymphocytes: role of cytokines and implications for fertility. J Immunol. 2001;166:7183-7189.
22. Ueda N, Yamanaka K, Yamamoto S. Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance. J Biol Chem. 2001;276:35552-35557.
23. Razandi M, Pedram A, Greene GL, Levin ER. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol Endocrinol. 1999;13:307-319.
24. Maccarrone M, Lorenzon T, Bari M, Melino G, Finazzi-Agrò A. Anandamide induces apoptosis in human cells via vanilloid receptors: Evidence for a protective role of cannabinoid receptors. J Biol Chem. 2000;275:31938-31945.
25. Khetawat G, Faraday N, Nealen ML, et al. Human megakaryocytes and platelets contain the estrogen receptor beta and androgen receptor (AR): Testosterone regulates AR expression. Blood. 2000;95:2289-2296.
26. Maccarrone M, Bari M, Finazzi-Agrò A. A sensitive and specific radiochromatographic assay of fatty acid amide hydrolase. Anal Biochem. 1999; 267:314-318.
27. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A. 1990;87:682-685.
28. Camacho M, Godessart N, Anton R, Garcia M, Vila L. Interleukin-1 enhances the ability of cultured human umbilical vein endothelial cells to oxidize linoleic acid. J Biol Chem. 1995;270: 17279-17286.
29. 31PNMR and enzyme activity study. J Lipid Res. 2000;41:985-990.
30. Brash AR. Lipoxygenases: Occurrence, functions, catalysis, and acquisition of substrate. J Biol Chem. 1999;274:23679-23682.
31. Stefano GB, Prevot V, Beauvillain JC, et al. Estradiol coupling to human monocyte nitric oxide release is dependent on intracellular calcium transients: Evidence for an estrogen surface receptor. J Immunol. 1999;163:3758-3763.
32. Pertwee RG. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther. 1997;74: 129-180.
33. Járai Z, Wagner J, Varga K, et al. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci U S A. 1999;96:14136-14141.
34. Piomelli D, Beltramo M, Glasnapp S, et al. Structural determinants for recognition and translocation by the anandamide transporter. Proc Natl Acad Sci U S A. 1999;96:5802-5807.
35. 2+ influx and phospholipase D activities of a rat brain-derived type-2 astrocyte cell line, RBA-2, are mediated through P2X7 receptors. J Neurochem. 1999;73:334-343.
36. Bourgoin S, Grinstein S. Peroxides of vanadate induce activation of phospholipase D in HL-60 cells: Role of tyrosine phosphorylation. J Biol Chem. 1992;267:11908-11916.
37. Liu J, Gao B, Mirshahi F, et al. Functional CB1 cannabinoid receptors in human vascular endothelial cells. Biochem J. 2000;346:835-840.
38. Beltramo M, Piomelli D. Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. Neuroreport. 2000;11:1231-1235.
39. Exton JH. New developments in phospholipase D. J Biol Chem. 1997;272:15579-15582.
40. Bisogno T, Maurelli S, Melck D, De Petrocellis L, Di Marzo V. Biosynthesis, uptake and degradation of anandamide and palmitoylethanolamide in leukocytes. J Biol Chem. 1997;272:3315-3323.
41. , Storey RF, Sanderson HM, White AE, May JA, Cameron KE, Heptinstall S. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity. Br J Haematol. 2000;110: 925-934.
42. Rogers KL, Grice ID, Griffiths LR. Modulation of in vitro platelet 5-HT release by species of Erythrina and Cymbopogon. Life Sci. 2001;69:1817-1829.
43. Najib A, Pelliccioni P, Gil C, Aguilera J. Serotonin transporter phosphorylation modulated by tetanus toxin. FEBS Lett. 2000;486:136-142.
44. Daniel JL, Dangelmaier C, Jin J, Ashby B, Smith JB, Kunapuli SP. Molecular basis for ADP-induced platelet activation, I: Evidence for three distinct ADP receptors on human platelets. J Biol Chem. 1998;273:2024-2029.
45. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW, Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest. 1999;103:401-406.
46. MacDonald JC, Vaughan CW. Cannabinoids act backwards. Nature. 2001;410:527-530.
47. Cenci S, Weitzmann MN, Roggia C, et al. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-α. J Clin Invest. 2000; 106:1229-1237.
48. Thomas EA, Carson MJ, Neal MJ, Sutcliffe JG. Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide. Proc Natl Acad Sci U S A. 1997;94: 14115-14119.
49. Hao S, Avraham Y, Mechoulam R, Berry EM. Low-dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. Eur J Pharmacol. 2000;392:147-156.
50. Giuffrida A, Rodriguez de Fonseca F, Piomelli D. Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry. Anal Biochem. 2000;280:87-93.